PUBLISHER: Grand View Research | PRODUCT CODE: 1363485
PUBLISHER: Grand View Research | PRODUCT CODE: 1363485
The global continuous bladder irrigation devices market size is anticipated to reach USD 1.87 billion by 2030, expected to grow at a CAGR of 4.7% from 2023 to 2030. According to a new report by Grand View Research, Inc.. The factors responsible for the market growth are an increase in the number of transurethral resections of the prostate (TURP) surgeries globally, a rise in the geriatric population, technological advancements, and increasing prevalence of urological disorders such as urinary tract infections (UTIs), prostate cancer, bladder cancer, and others. According to the American Cancer Society, in 2022, approximately 268,490 new cases of prostate cancer will be identified in the U.S., and 34,500 men will die from the disease.
Increased awareness among healthcare professionals and patients about the benefits of CBI in post-operative care and infection prevention contributes to market growth. For instance, in September 2022, the Urology Foundation organized Urology Awareness Month, which aims to increase public awareness of urological diseases and conditions as well as collect funds for essential research and training for healthcare professionals treating these conditions.
The prevalence of bladder-related conditions and procedures, like bladder tumor removal and transurethral resection of the prostate (TURP), is rising in aging population because aging people are more prone to these conditions, so there is a greater need for CBI devices. For instance, in January 2023, the American Cancer Society stated that about 9 out of 10 people with bladder cancer are over the age of 55, and the average age of people when they are diagnosed is 73.